12
Total investments
7
Early stage
0
Mid stage
1
Late stage
9y
Years active
Portfolio
12 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor / Advisor
Mar 2026
Tacit is an applied research lab at the intersection of AI and the life sciences.
Investor / Advisor
Sep 2025
Phylo is an applied research lab dedicated to studying agentic intelligence to accelerate discoveries for every biomedical scientist. Building Biomni Lab - the first integrated biology environment.
Investor / Advisor
2024
Axiom helps scientists eliminate molecular toxicity by providing the most accurate and affordable predictive models. Our proprietary dataset includes more than 100,000 molecules tested in pooled primary human liver cells, tens of thousands of molecules with pharmacokinetic measurements, and thousands of molecules with curated clinical outcome data. Axioms AI models offer higher accuracy than advanced in vitro systems like 3d spheroids, deep mechanistic understanding which untangles mitochondrial toxicity, ER stress, ROS formation, cytotoxicity, and more, and precise risk assessment for any molecule at relevant clinical dosage and clinical exposure levels. Our models remove the need for costly physical experiments, giving more accurate and cheaper toxicity assessments, and empowering scientists to make better-informed decisions and bring safer drugs to the clinic.
Investor / Advisor
Jul 2023
Jimini’s mission is to radically improve the efficacy of mental health care across the world. Jimini has developed Sage, the world’s first AI behavioral health team member. Sage works as an always-available assistant alongside licensed providers, giving patients personalized support throughout their entire care journey. Sage benefits patients, providers, and organizations by enhancing outcomes, retention, and efficiency in ways previously unattainable.
Founded in 2023 by a team of seasoned AI and biotech entrepreneurs, health tech veterans, and psychology researchers, Jimini uses science and tech to put patients first. Our safe, purpose-built technology works exclusively under clinical oversight and with high safety standards.
World leaders in psychology designed Sage to maximize the efficacy of every stage of the patient journey. We do not believe LLMs should replace providers; instead, Sage empowers providers to deliver higher-quality care, focus on the most complex parts of their work, and extend their impact beyond the limited time with each patient.
Jimini is committed to improving mental health quality and creating radically better, more modern, and clinically efficacious mental health experiences for patients.
Investor / Observer
Aug 2022
Noetik is an AI-native biotechnology company. By harnessing the potential of self-supervised learning and human multimodal data, Noetik aims to discover better precision immunotherapies.
Investor
Jun 2022
Building software to let you track your science across teams and tools: collaborate on projects, plan around compounds, candidates, or samples, and manage workflows, all in one spot.
Investor / Observer
Oct 2021
We develop AI and wet-lab technologies that enable the rational design of developable, selective, and functional drugs against previously undruggable targets.
To maximize the patient impact of our platform, we collaborate with leading pharmaceutical companies, including AstraZeneca, Bristol Myers Squibb and Takeda, to expand their pipelines with high-quality drug candidates.
If successful we could double the number of disease-relevant drug targets the industry advances for drug development.
Since launching in 2021 we have raised $37 million with the backing of leading investors, including Radical Ventures, Khosla Ventures and Zetta Venture Partners.
Our technical team is based in Cambridge, Massachusetts and continues to recruit top machine learning and synthetic biology talent. For more information check out the Careers section of our website at www.nabla.bio.
Investor
Jun 2018
Meat without the animal, for a more sustainable food system
We're hiring! Join us on the path to creating a more sensible food system for the world: https://www.missionbarns.com/careers
Investor
Feb 2018
Might Buildings is now a brand of LUMUS, an advanced manufacturing and material science company redefining how the world builds. By combining proprietary 3D printing technology, sustainable inorganic materials, and deep construction expertise, we deliver faster, more resilient and sustainable building solutions.
Our flagship product brand, Mighty Buildings, features the Mighty Wall System—a next-generation wall solution that accelerates construction timelines, enhances performance and design, and offers a scalable path to addressing global housing shortages.
The Mighty Wall System is a flexible set of ready-to-install wall panels built off-site with precision manufacturing using our proprietary LUMUS® material. Each panel arrives installation-ready—complete with integrated structure, insulation, waterproofing, and a finished exterior surface. Instead of assembling walls piece by piece, developers and builders can create full structures in a fraction of the time while still using familiar construction methods.
Panels connect seamlessly, forming durable, energy-efficient buildings with clean, modern aesthetics. Available in multiple textures and colors, our 3D-printed exteriors deliver a finished look that performs as beautifully as it appears.
At LUMUS, we’re building the future of construction today—efficient, sustainable, and beautifully executed.
Investor
Jan 2018
Fox Robotics is mid-stage startup working on warehouse automation. Our automated forklifts have the most advanced technology in the industry and are the only equipment capable of more complicated tasks such as trailer unloading. The team behind our products is incredible and growing quickly.
We’re based in Austin, TX.
Investor
Dec 2017
Elementary helps Fortune 500 manufacturers automate inspection, increase production yield, and achieve measurable ROI in less than 6 months.
Our industrial-grade inspection stations and QA platform deliver high-speed inspection, advanced defect detection, and real-time root cause analysis—empowering manufacturers to reduce downtime and drive digital transformation on the factory floor.
Experience · 16 entries
All (16)
Investments (12)
Founder (1)
2026
Investor / Advisor
Mar 2026
Tacit is an applied research lab at the intersection of AI and the life sciences.
2025
Investor / Advisor
Sep 2025
Phylo is an applied research lab dedicated to studying agentic intelligence to accelerate discoveries for every biomedical scientist. Building Biomni Lab - the first integrated biology environment.
2024
Investor / Advisor
2024
Axiom helps scientists eliminate molecular toxicity by providing the most accurate and affordable predictive models. Our proprietary dataset includes more than 100,000 molecules tested in pooled primary human liver cells, tens of thousands of molecules with pharmacokinetic measurements, and thousands of molecules with curated clinical outcome data. Axioms AI models offer higher accuracy than advanced in vitro systems like 3d spheroids, deep mechanistic understanding which untangles mitochondrial toxicity, ER stress, ROS formation, cytotoxicity, and more, and precise risk assessment for any molecule at relevant clinical dosage and clinical exposure levels. Our models remove the need for costly physical experiments, giving more accurate and cheaper toxicity assessments, and empowering scientists to make better-informed decisions and bring safer drugs to the clinic.
2023
Investor / Advisor
Jul 2023
Jimini’s mission is to radically improve the efficacy of mental health care across the world. Jimini has developed Sage, the world’s first AI behavioral health team member. Sage works as an always-available assistant alongside licensed providers, giving patients personalized support throughout their entire care journey. Sage benefits patients, providers, and organizations by enhancing outcomes, retention, and efficiency in ways previously unattainable.
Founded in 2023 by a team of seasoned AI and biotech entrepreneurs, health tech veterans, and psychology researchers, Jimini uses science and tech to put patients first. Our safe, purpose-built technology works exclusively under clinical oversight and with high safety standards.
World leaders in psychology designed Sage to maximize the efficacy of every stage of the patient journey. We do not believe LLMs should replace providers; instead, Sage empowers providers to deliver higher-quality care, focus on the most complex parts of their work, and extend their impact beyond the limited time with each patient.
Jimini is committed to improving mental health quality and creating radically better, more modern, and clinically efficacious mental health experiences for patients.
2022
Investor / Observer
Aug 2022
Noetik is an AI-native biotechnology company. By harnessing the potential of self-supervised learning and human multimodal data, Noetik aims to discover better precision immunotherapies.
Show all 16 entries ↓
Investment activity
2017–2026 · 12 investments
Recent (last 2 years)Earlier
